Cellebrite DI Ltd.

Is Cellebrite a public company?

Yes. Cellebrite DI Ltd. trades on Nasdaq under the ticker CLBT. It listed in August 2021 through a merger with the SPAC TWC Tech Holdings II Corp. at an implied valuation of approximately $2.4 billion.

Who owns Cellebrite?

Ownership is split between public shareholders and a dominant strategic holder. Sun Corporation of Japan, which acquired the company in 2007, remains the largest shareholder, holding roughly half of shares after the 2021 listing. Israel Growth Partners is the other legacy private holder.

When was Cellebrite founded and by whom?

Cellebrite was founded in Israel in 1999 by Avi Yablonka, Yaron Baratz, and Yuval Aflalo. It originally built phone-to-phone data transfer hardware for retailers before launching its mobile forensics business in 2007.

What does Cellebrite sell?

The company sells digital intelligence and forensics software: the Inseyets suite for extracting and decoding device data, Guardian for cloud evidence management, Pathfinder for investigative analytics, Advanced Access unlocking services, and Corellium's mobile virtualization platform.

What was Cellebrite's revenue in 2025?

Fiscal 2025 revenue was $475.7 million, up 19% year on year, with subscription revenue of $427.0 million, GAAP net income of $78.3 million, and adjusted EBITDA of $127.6 million.

Where is Cellebrite headquartered?

The company is dual headquartered in Petah Tikva, Israel, where its engineering and R&D operations are centered, and Tysons Corner, Virginia, near its largest base of U.S. federal customers.

Who leads Cellebrite?

Thomas E. Hogan has served as CEO since late 2024, succeeding longtime chief executive Yossi Carmil, who retired after leading the company for two decades.

Cellebrite was established in Israel in 1999 by Avi Yablonka, Yaron Baratz, and Yuval Aflalo. The founding business was hardware for mobile phone retailers: devices that transferred contacts and user data between handsets, a service carriers offered customers during upgrades. The company grew without external venture capital, an unusual path for an Israeli technology firm.

Ron Serber joined in 2001 and Yossi Carmil in 2004, and the two became co-CEOs in 2005. In 2007 the company made two linked moves that defined its future: it launched a mobile forensics division building the Universal Forensic Extraction Device (UFED), and it was acquired by FutureDial and its major shareholder Sun Corporation of Japan for a reported $17 million. Carmil has said publicly that the founders sold cheaply because they wanted to exit a company that had grown entirely on operating cash flow.

The UFED line arrived just as smartphones became ubiquitous. Through the 2010s the device became standard kit in police forensic labs, and the company layered on software: Physical Analyzer for decoding extracted data, Reader for report review, and later the Pathfinder analytics platform for correlating evidence across large investigative datasets. International expansion followed, with offices added in Washington, Munich, Singapore, and other regional centers. By the early 2020s the company counted roughly 6,700 customer organizations across more than 140 countries and employed 850 people, about 500 in Israel.

The 2016 San Bernardino iPhone episode, in which press reports speculated Cellebrite had helped the FBI access the shooter's device, pushed the company into mainstream news coverage for the first time. Cellebrite never confirmed involvement, but the association fixed its public identity as the company police call when a phone will not open.

The company went public in August 2021 through a merger with TWC Tech Holdings II Corp., a special purpose acquisition company, listing on Nasdaq as CLBT at an implied equity value around $2.4 billion. The transaction left Sun Corporation holding about 51% of the combined company and Israel Growth Partners roughly 17%.

Under CEO Thomas E. Hogan, who succeeded Yossi Carmil in late 2024, the company has pushed two priorities: converting the installed base to the subscription-based Inseyets platform, and expanding through acquisition. On December 1, 2025 it completed the purchase of Corellium, a mobile virtualization company, in its first major deal since listing. Fiscal 2025 closed with $475.7 million in revenue, up 19%, and management guided fiscal 2026 revenue to a range of $565 million to $571 million.

Cellebrite operates one of the most scrutinized business models in enterprise software because its core product defeats the security controls of consumer devices.

Documented scrutiny includes a 2021 civil society letter opposing its public listing over sales to governments accused of human rights abuses, reporting that placed UFED units in Bangladesh, Belarus, China, Myanmar, Russia, and Venezuela, and Amnesty International's 2024 to 2025 documentation of Serbian police using Cellebrite tools to unlock the phones of a journalist and an activist detained amid the Novi Sad protests. Cellebrite responded that those uses violated its licensing terms, announced restrictions on the Serbian agencies involved, and has said it ended sales to Russia, Belarus, China, Hong Kong, and Macau.

In the United States, civil liberties organizations have pressed for warrant standards and transparency around police use of phone extraction tools, with Cellebrite frequently cited as the dominant vendor. The company maintains an ethics and integrity framework requiring customers to confirm lawful use, and states it investigates reported misuse.